Want to join the conversation?
In the year ended December 31, 2015, $AGN's integration and restructuring charges were primarily related to the integration of the Legacy Allergan business and the Forest acquisition. In the year ended Dec. 31, 2015, $AGN had $1.15Bil in cost of sales primarily related to the fair value inventory step-up from the Allergan and Forest acquisitions.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.